Form 4 for TWST Twist Bioscience Corp
Accepted 2023-05-25 00:00:00 ET · period of report 2023-05-23 · accession 0001214659-23-007821 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-25 | 2023-05-23 | TWST | THORBURN JAMES M | CFO | M - OptEx | $11.59 | +13.3K | 62.0K | +27% | +$154.4K |
| D | 2023-05-25 | 2023-05-23 | TWST | THORBURN JAMES M | CFO | M - OptEx | $0.00 | -13.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-23 | M | A | 13,324 | $11.59 | 62,042 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-05-23 | M | D | 13,324 | $0.00 | 0 | D | $11.59 · — to 2028-06-06 | 13,324 Common Stock | (F1) The option is immediately exercisable. 25% of the shares subject to the option vested on April 23, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |